The Calgary-based life sciences company hopes to develop treatments for mental health conditions.
Sublingual or the administration of medicines under the tongue allows for quick absorption.
The Toronto company is developing a psychedelic drug for anxiety disorders.
Australian researcher cites need to explore ethical issues regarding the use of psychedelics as medicine.
People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.
Toronto-based biotechnology company Awakn has a research program on ketamine-assisted psychotherapy against multiple addictions.
Vancouver biotechnology company Havn Life will export yield to UBC-based Delic Labs for quality control and testing.
Petter Grahl Johnstad of the University of Bergen says a bad psychedelics trip can be a way to confront personal demons.
A study in Argentina finds association between the use of psychedelic substances with positive mental health outcomes.